Lumitao, Danica T.

HRN: 23-71-34  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/13/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/13/2026
02/20/2026
IV
500mg
Q8
Acute Appendicitis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominalProphylaxis    Compliance to guidelines: Compliant To Guidelines